DE LAURENTIIS, MICHELINO
DE LAURENTIIS, MICHELINO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGICA
Neural network analysis for evaluating cancer risk in thyroid nodules with an indeterminate diagnosis at aspiration cytology: identification of a low-risk subgroup.
2004 Antonio M., Ippolito; DE LAURENTIIS, Michelino; Giacomo L., La; Antonio, Eleuteri; Roberto, Tagliaferri; DE PLACIDO, Sabino; Riccardo, Vigneri; Antonino, Belfiore
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.
2003 DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino
Prognosis of chronic myelomonocytic leukemia.
1996 L., Catalano; S., Improta; DE LAURENTIIS, Michelino; S., Molica; I., Majolino; P., Musto; A., Fragasso; DE PLACIDO, Sabino; Rotoli, Bruno
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer.
2006 Ciardiello, F; Troiani, T; Caputo, F; DE LAURENTIIS, Michelino; Tortora, G; Palmieri, Giovannella; De Vita, F; Diadema, Mr; Orditura, M; Colantuoni, G; Gridelli, C; Catalano, G; DE PLACIDO, Sabino; Bianco, A. R.
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: a phase I clinical trial.
2007 Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Valeria, Forestieri; Carmela, Romano; Antonella, Prudente; Francesco, Giugliano; Ciro, Imbimbo; Vincenzo, Mirone; DE PLACIDO, Sabino
Differential immunohistochemical detection of transforming growth factor , amphiregulin and CRIPTO in human normal and malignant breast tissues.
1996 Panico, L.; D'Antonio, A.; Salvatore, G.; Mazza, E.; Tortora, Giampaolo; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Giordano, T.; Merino, M.; Salomon, D. S.; Gullick, W. J.; Pettinato, Guido; Bianco, A. R.; Ciardiello, F.
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A.
1996 Ciardiello, Fortunato; Damiano, Vincenzo; Bianco, Roberto; C., Bianco; G., Fontanini; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; J., Mendelsohn; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo
NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA
2000 Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Treatment of triple negative brest cancer (TNBC): current options and future perspectives.
2010 DE LAURENTIIS, Michelino; Cianniello, Daniela; Caputo, Roberta; Stanzione, Brigida; Arpino, Grazia; Cinieri, S; Lorusso, V; DE PLACIDO, Sabino
A technique for using neural network analysis to perform survival analysis of censored data.
1994 DE LAURENTIIS, Michelino; P. M., Ravdin
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
1998 DE PLACIDO, Sabino; Carlomagno, C.; DE LAURENTIIS, Michelino; Bianco, A. R.
DNA-flow cytometry (ploidy and S-phase fraction) as prognostic factor in a retrospectine series of 515 primary breast cancer.
1995 Pepe, S.; Ruggiero, A.; DE LAURENTIIS, Michelino; Normanno, N.; Fiorentino, B.; Perrone, F.; Carlomagno, Chiara; DE PLACIDO, Sabino; Panico, L.; Pettinato, Guido; Borriello, G.; Bianco, ANGELO RAFFAELE
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
2005 Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?
1996 F., Perrone; Carlomagno, Chiara; R., Lauria; DE LAURENTIIS, Michelino; A., Morabito; L., Panico; Pettinato, Guido; G., Petrella; C., Gallo; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
A predictive index of axillary nodal involvement in operable breast cancer.
1996 DE LAURENTIIS, Michelino; C., Gallo; DE PLACIDO, Sabino; F., Perrone; Pettinato, Guido; G., Petrella; Carlomagno, Chiara; L., Panico; P., Delrio; Bianco, ANGELO RAFFAELE
A-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies.
1996 Caraglia, M.; Leardi, A.; Ricciardi, B.; DE LAURENTIIS, Michelino; Lentini, M. L.; Graziano, ; Matano, Elide; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Tagliaferri, P.
Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer.
1995 Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients.
2011 Giordano, A; Giuliano, Mario; DE LAURENTIIS, Michelino; Eleuteri, A; Iorio, F; Tagliaferri, R; Hortobagyi, Gn; Pusztai, L; DE PLACIDO, Sabino; Hess, K; Cristofanilli, M; Reuben, Jm
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
1999 DE PLACIDO, Sabino; Lauria, Rossella; Carlomagno, Chiara; F., Perrone; DE LAURENTIIS, Michelino; C., Gallo; A., Martignetti; T., Bellelli; Limite, Gennaro; Petrella, Giuseppe; Bianco, ANGELO RAFFAELE
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer.
1993 F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; F., Nuzzo; A., Ruggiero; DE LAURENTIIS, Michelino; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Neural network analysis for evaluating cancer risk in thyroid nodules with an indeterminate diagnosis at aspiration cytology: identification of a low-risk subgroup. | 1.1 Articolo in rivista | 2004 | Antonio M., Ippolito; DE LAURENTIIS, Michelino; Giacomo L., La; Antonio, Eleuteri; Roberto, Tagliaferri; DE PLACIDO, Sabino; Riccardo, Vigneri; Antonino, Belfiore | |
| Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. | 1.1 Articolo in rivista | 2003 | DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino | |
| Prognosis of chronic myelomonocytic leukemia. | 1.1 Articolo in rivista | 1996 | L., Catalano; S., Improta; DE LAURENTIIS, Michelino; S., Molica; I., Majolino; P., Musto; A., Fragasso; DE PLACIDO, Sabino; Rotoli, Bruno | |
| Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer. | 1.1 Articolo in rivista | 2006 | Ciardiello, F; Troiani, T; Caputo, F; DE LAURENTIIS, Michelino; Tortora, G; Palmieri, Giovannella; De Vita, F; Diadema, Mr; Orditura, M; Colantuoni, G; Gridelli, C; Catalano, G; DE PLACIDO, Sabino; Bianco, A. R. | |
| Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: a phase I clinical trial. | 1.1 Articolo in rivista | 2007 | Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Valeria, Forestieri; Carmela, Romano; Antonella, Prudente; Francesco, Giugliano; Ciro, Imbimbo; Vincenzo, Mirone; DE PLACIDO, Sabino | |
| Differential immunohistochemical detection of transforming growth factor , amphiregulin and CRIPTO in human normal and malignant breast tissues. | 1.1 Articolo in rivista | 1996 | Panico, L.; D'Antonio, A.; Salvatore, G.; Mazza, E.; Tortora, Giampaolo; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Giordano, T.; Merino, M.; Salomon, D. S.; Gullick, W. J.; Pettinato, Guido; Bianco, A. R.; Ciardiello, F. | |
| Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. | 1.1 Articolo in rivista | 1996 | Ciardiello, Fortunato; Damiano, Vincenzo; Bianco, Roberto; C., Bianco; G., Fontanini; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; J., Mendelsohn; Bianco, ANGELO RAFFAELE; Tortora, Giampaolo | |
| NUCLEAR DNA CONTENT-DERIVED PARAMETERS CORRELATED WITH HETEROGENEOUS EXPRESSION PF P53 AND BCL-2 PROTEINS IN CLEAR CELL RENAL CARCINOMA | 1.1 Articolo in rivista | 2000 | Pepe, S; Ruggiero, A; D'Acquisto, M; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Treatment of triple negative brest cancer (TNBC): current options and future perspectives. | 1.1 Articolo in rivista | 2010 | DE LAURENTIIS, Michelino; Cianniello, Daniela; Caputo, Roberta; Stanzione, Brigida; Arpino, Grazia; Cinieri, S; Lorusso, V; DE PLACIDO, Sabino | |
| A technique for using neural network analysis to perform survival analysis of censored data. | 1.1 Articolo in rivista | 1994 | DE LAURENTIIS, Michelino; P. M., Ravdin | |
| c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients. | 1.1 Articolo in rivista | 1998 | DE PLACIDO, Sabino; Carlomagno, C.; DE LAURENTIIS, Michelino; Bianco, A. R. | |
| DNA-flow cytometry (ploidy and S-phase fraction) as prognostic factor in a retrospectine series of 515 primary breast cancer. | 1.1 Articolo in rivista | 1995 | Pepe, S.; Ruggiero, A.; DE LAURENTIIS, Michelino; Normanno, N.; Fiorentino, B.; Perrone, F.; Carlomagno, Chiara; DE PLACIDO, Sabino; Panico, L.; Pettinato, Guido; Borriello, G.; Bianco, ANGELO RAFFAELE | |
| Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. | 1.1 Articolo in rivista | 2005 | Early Breast Cancer Trialists' Collaborative, Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino | |
| Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? | 1.1 Articolo in rivista | 1996 | F., Perrone; Carlomagno, Chiara; R., Lauria; DE LAURENTIIS, Michelino; A., Morabito; L., Panico; Pettinato, Guido; G., Petrella; C., Gallo; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| A predictive index of axillary nodal involvement in operable breast cancer. | 1.1 Articolo in rivista | 1996 | DE LAURENTIIS, Michelino; C., Gallo; DE PLACIDO, Sabino; F., Perrone; Pettinato, Guido; G., Petrella; Carlomagno, Chiara; L., Panico; P., Delrio; Bianco, ANGELO RAFFAELE | |
| A-Interferon potentiates the growth inhibitory effects of anti-transferrin receptor monoclonal antibodies. | 1.1 Articolo in rivista | 1996 | Caraglia, M.; Leardi, A.; Ricciardi, B.; DE LAURENTIIS, Michelino; Lentini, M. L.; Graziano, ; Matano, Elide; DE PLACIDO, Sabino; Bianco, ANGELO RAFFAELE; Tagliaferri, P. | |
| Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer. | 1.1 Articolo in rivista | 1995 | Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Artificial neural network analysis of circulating tumor cells in metastatic breast cancer patients. | 1.1 Articolo in rivista | 2011 | Giordano, A; Giuliano, Mario; DE LAURENTIIS, Michelino; Eleuteri, A; Iorio, F; Tagliaferri, R; Hortobagyi, Gn; Pusztai, L; DE PLACIDO, Sabino; Hess, K; Cristofanilli, M; Reuben, Jm | |
| The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. | 1.1 Articolo in rivista | 1999 | DE PLACIDO, Sabino; Lauria, Rossella; Carlomagno, Chiara; F., Perrone; DE LAURENTIIS, Michelino; C., Gallo; A., Martignetti; T., Bellelli; Limite, Gennaro; Petrella, Giuseppe; Bianco, ANGELO RAFFAELE | |
| Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer. | 1.1 Articolo in rivista | 1993 | F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; F., Nuzzo; A., Ruggiero; DE LAURENTIIS, Michelino; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE |